Metsera (MTSR) Shares Soar on Pfizer’s $7.3B Buyout
Metsera Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical company founded in 2022 with a focus on developing next-generation therapies…
Quantum BioPharma (QNTM) Eyes $250M in Royalties From Unbuzzd Wellness Deal
Quantum BioPharma Ltd. (NASDAQ:QNTM) is a biopharmaceutical company committed to developing innovative therapeutic assets that address some of…
Analysts See 127% Upside for Intellia (NTLA) After $14.99 Surge
Intellia Therapeutics Inc. (NASDAQ:NTLA) is a pioneering genome editing company founded in 2014 with the mission to develop…
Oscar Health (OSCR) Reports $2.86B Revenue in Q2 2025
Oscar Health Inc. (NYSE:OSCR) is a technology-driven health insurance company founded in 2012 with the mission of making…
UnitedHealth (UNH)’s Q3 Earnings Forecast Crashes Nearly 60%
UnitedHealth Group Incorporated (NYSE:UNH) is one of the largest and most influential health care companies in the United…
Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the…
Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss
Trulieve Cannabis Corp. (OTC:TCNNF) is one of the largest and most established multi-state cannabis operators in the United…
BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is a biotechnology company dedicated to discovering and developing innovative oral therapies for rare…
Novo Nordisk (NVO) Crashes 21.83% in One Day
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company with a history that spans more than a century,…
Connect Biopharma (CNTB) Trades at $1.63 With $7.00 Analyst Target
Connect Biopharma Holdings Limited (NASDAQ:CNTB) is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative therapies for…
Ocean Biomedical (OCEA) Warned Over Missed $612,581 Milestone
Ocean Biomedical, Inc. (NASDAQ:OCEA) is a clinical-stage biopharmaceutical company that was established with a mission to bridge the…
Greenwich LifeSciences (GLSI)’ GLSI-100 Cuts Breast Cancer Recurrence by 80% in Trials
Greenwich LifeSciences Inc. (NASDAQ:GLSI) is a clinical-stage biopharmaceutical company dedicated to developing novel immunotherapies designed to prevent breast…
SELLAS Life (SLS) Secures $23.6M to Fuel Late-Stage Cancer Trials
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company dedicated to developing innovative therapies for…
Adicet (ACET) Falls Despite $150.4M Cash Runway Into 2026
Adicet Bio, Inc. (NASDAQ:ACET) is a clinical-stage biotechnology company focused on discovering and developing innovative allogeneic gamma delta…
Enlivex (ENLV) Reports $1.87M Q2 Loss, Cuts Cash Burn Nearly 40%
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) is a clinical-stage biopharmaceutical company based in Israel that is pioneering a novel approach…
BiomX (PHGE) Surges as BX211 Cuts Diabetic Wounds by 40%
BiomX Inc. (NASDAQ:PHGE) is a clinical-stage biotechnology company pioneering the development of bacteriophage-based therapies designed to target harmful…
MeiraGTx (MGTX) Reports $3.69M Revenue
MeiraGTx Holdings plc (NASDAQ:MGTX) is a clinical-stage gene therapy company dedicated to developing transformative treatments for patients with…
CytomX (CTMX) Boosts Cash to $158.1M After $100M Raise
CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biotechnology company dedicated to transforming the treatment of cancer through its…